RECENT NEWS

Diagnexia has announced an exclusive partnership with Artera to bring the ArteraAI Prostate Biopsy Assay to the UK.

The IBMS and global innovation consultancy PA Consulting have released the second paper in the ‘Earlier Diagnostics’ series, offering a strategic blueprint for optimising UK diagnostic services.

Revvity has expanded its alliance with Genomics England to further collaborate on the Generation Study. Under the new contract, Revvity will now also provide DNA sequencing services to help screen newborns for rare genetic conditions.

Mindpeak is to partner with AstraZeneca to deploy and evaluate AI-powered digital pathology risk assessment tools for breast cancer. The new collaboration will evaluate Mindpeak Breast H&E AI software for primary breast cancer diagnosis in Brazil, Egypt, and Kenya.

Pathology software company Aiosyn and Pramana, a company supplying automated digital pathology solutions, have announced a collaboration to deliver inline detection of kidney structures in histology whole-slide images (WSIs).

The UK Health Security Agency (UKHSA) has expanded the list of notifiable diseases and pathogens that registered medical professionals and diagnostic laboratories in England must report.

HistoIndex, a global leader in stain-free digital pathology solutions for managing fibrotic diseases, has announced the launch of its first laboratory developed test (LDT) FibroSIGHT.

NHS England has announced the incoming team who will help lead the organisation’s transition into the Department of Health and Social Care.

The UK Health Security Agency (UKHSA) has launched genomic surveillance of hepatitis C virus (HCV) in a bid to monitor drug resistance, tackle harder to treat viral strains, and detect outbreaks sooner.

The Medicines and Healthcare products Regulatory Agency (MHRA) welcomed Health Minister Karin Smyth MP to its science campus recently as part of British Science Week to demonstrate how innovations become safe, effective treatments for NHS patients.

The government has revealed more details on how the functions of NHS England will be absorbed into the Department of Health and Social Care (DHSC), saying the move will reduce bureaucracy, make savings and empower NHS staff to deliver better care for patients.

Prime Minister Sir Keir Starmer has announced that NHS England will be abolished to "cut bureaucracy" and bring management of the health service "back into democratic control", in a speech on 13 March about reshaping the state and civil service.

Veterinary microbiologists and pathologists are at the forefront of addressing antimicrobial resistance in animals. A new position statement from The Royal College of Pathologists (RCPath) focuses on a series of recommendations to help tackle this global threat.

NHS England has announced changes to its leadership team, with three leading board members taking the decision to stand down at the end of March, ahead of a restructure which could see the body halve in size.

Dyfed Alsop has been appointed as the new Chief Operating Officer and Deputy Chief Executive Officer of the UK Health Security Agency (UKHSA), starting 1 May 2025.

ARUP Laboratories has expanded its AI-augmented screening tool for the detection of human gastrointestinal parasites to include wet-mount slides. With this expansion, ARUP Laboratories will become the first and only laboratory to apply AI-augmented screening to the entire ova and parasite testing process.

Liquid biopsy platform firm Tethis and Israel-based Sheba Medical Center have announced a research collaboration to evaluate circulating tumour cells (CTCs) in rectal cancer patients using Tethis' proprietary technology.

Previous IBMS President and Clinical Pathology Lead and Lead Healthcare Scientist Debra Padgett has been awarded an Honorary Fellowship from The Royal College of Pathologists (RCPath) in recognition of her outstanding contributions to pathology and biomedical science.

Medical robotics firm Vitestro has unveiled its autonomous blood drawing device: Aletta, the first autonomous robotic device designed to perform automated blood draws.

Beckman Coulter Life Sciences - in a new partnership with Rarity Bioscience AB - offers a new approach to oncology research by extending the capabilities of flow cytometry to clinical molecular research.